Par Pharmaceuticals agrees $100m patent settlement

Managing IP Correspondent

September 23, 2014

Par Pharmaceuticals has agreed to pay $100 million to a unit of Salix Pharmaceuticals and the University of Missouri to settle a lawsuit alleging it had infringed two patents related to the heartburn drug Zegerid

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login

Topics

Managing IP Correspondent

More from across our site

‘Unhelpful’ WTO in deadlock over TRIPS waiver extension

Civil society and industry representatives met in Geneva on Thursday, September 28 to discuss a potential expansion of the TRIPS waiver

Rory O’Neill, September 29, 2023

A collage on the subject of seo. Contemporary composition with a hand holding a magnifying glass. Attracting new users. Vector yellow background.

USPTO’s new TM search tool raises clearance pricing questions

Sources say the beta version of the USPTO’s new trademark search tool is a big improvement over the current system but that it isn’t perfect

Rani Mehta, September 29, 2023

'Now's the time’: counsel urge TM renewal spree before fee hike

Canadian counsel weigh in on the IP office’s decision to raise trademark filing fees in 2024 and how they’re preparing clients

Rani Mehta, September 29, 2023

Chongqing city night view and skyline of architectural landscape

This week on MIP: Rouse expansion plans, China's TM watershed

We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP

Rory O’Neill, September 29, 2023

AI ethics or AI Law concept. Developing AI codes of ethics. Compliance, regulation, standard , business policy and responsibility for guarding against unintended bias in machine learning algorithms

US Copyright Office head: we are a ‘natural lab’ for AI

Shira Perlmutter, US Register of Copyrights, discussed the Copyright Office's role in forming generative AI policy during a House of Representatives hearing

Rani Mehta, September 28, 2023

Assa Abloy wins $14m TM award at China’s top court

The award marks one of the highest-ever damages received by a foreign company in a trademark infringement suit in China

Sukanya Sarkar, September 28, 2023

Lawyers: UPC 'black box' needs more transparency

Two orders denying public access to documents have reignited a debate over a lack of transparency at the new court

Rory O’Neill, September 28, 2023

‘Tesla of IP’: new Rouse COO talks expansion plans

Rouse’s new chief of operations and the firm’s CEO tell Managing IP why they think private equity backing will help it conquer Europe

Rory O’Neill, September 28, 2023

Cyber security protection for safety computer network, safety shield to protect online threat or attack, digital privacy or encryption concept, man hold shield on computer laptop protect cyber attack.

How to guard against challenges to Patent Term Adjustment post-Cellect

Brian Landry, partner at Saul Ewing, reveals how applicants can prosecute patent applications in the wake of the Federal Circuit's In re Cellect ruling

Brian Landry, September 28, 2023

Technology literacy in law and policy is now critical

Ronelle Geldenhuys of Australia’s Foundry IP considers the implications complex computer technologies such as AI have on decision-making

Ronelle Geldenhuys, September 27, 2023